Literature DB >> 3048904

Abdominal cryptococcoma in AIDS: a case report.

F P Scalfano1, J G Prichard, N Lamki, P A Athey, R C Graves.   

Abstract

Cryptococcosis is a recognized opportunistic pathogen in the acquired immune deficiency syndrome. Although central nervous system infection and disseminated cryptococcosis is common in acquired immune deficiency syndrome, localized infection is rare. We present a case of massive retroperitoneal and mesenteric adenopathy in a male homosexual patient with acquired immune deficiency syndrome with clinical and radiologic features suggestive of lymphoma. However, this was proven pathologically to represent cryptococcal infiltration of the lymph nodes. Our experience indicates that Cryptococcus neoformans should be included in the differential diagnosis of massive abdominal adenopathy in the acquired immune deficiency syndrome.

Entities:  

Mesh:

Year:  1988        PMID: 3048904     DOI: 10.1016/0149-936x(88)90017-3

Source DB:  PubMed          Journal:  J Comput Tomogr        ISSN: 0149-936X


  4 in total

1.  Intraabdominal cryptococcal lymphadenitis in a patient with systemic lupus erythematosus.

Authors:  Sang-Hyon Kim; Sung-Dong Kim; Hae-Rim Kim; Chong-Hyeon Yoon; Sang-Heon Lee; Ho-Youn Kim; Sung-Hwan Park
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

2.  Case report-right iliac fossa mass in an HIV-positive woman. Cryptococcal meningitis.

Authors:  J J Kumwenda; M Nyirenda; T Tomoka; D Ricken; K Chalulu; S Kamiza
Journal:  Malawi Med J       Date:  2010-06       Impact factor: 0.875

Review 3.  Intra-abdominal cryptococcosis by Cryptococcus gattii: case report and review.

Authors:  Bruno S Araújo; Monica Bay; Roberta Reichert; Luciano Z Goldani
Journal:  Mycopathologia       Date:  2012-01-14       Impact factor: 2.574

4.  Cryptococcal mesenteric lymphadenitis: an unusual cause of acute abdomen.

Authors:  Güngör Karagüzel; Bahar Kiliçarslan-Akkaya; Mustafa Melikoğlu; Gülten Karpuzoğlu
Journal:  Pediatr Surg Int       Date:  2004-08-13       Impact factor: 1.827

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.